Hepion Pharmaceuticals names Dr. Stephen Harrison consultant medical director — 3 insights

Hepion Pharmaceuticals named Stephen Harrison, MD, consultant medical director.

Advertisement

What you should know:

1. Dr. Harrison is a visiting professor of hepatology at the University of Oxford in England. He is internationally known for his work around hepatitis C and nonalcoholic fatty liver disease. He’s published more than 200 studies on these subjects to date.

2. He has served in a number of roles throughout his career, including a 20-year tenure with the U.S. Army. He retired in 2016 as a colonel.

3. Dr. Harrison earned his medical degree from Jackson-based University of Mississippi School of Medicine. He completed a residency and fellowship at San Antonio-based Brooke Army Medical Center and then completed an advanced liver disease fellowship at Saint Louis University.

More articles on surgery centers: 
Dr. Ravi Bashyal: Key trends in outpatient knee, hip surgery
Orthopedic surgeon joins staff at the Steadman Clinic
3 orthopedics-focused ASCs that opened or expanded in September

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.